Search - tctmd.com

Displaying 601 - 620 of 914

Sort: Relevancy | Date

News Conference News ESC 2017

Underweight and Overlooked: Low BMI Patients May Be Highest-Risk Post-PCI

Shelley Wood

August 26, 2017

News Daily News

TAVR in the US: Regional Variations in Numbers, Outcomes

Michael O'Riordan

August 22, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Daily News

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

Todd Neale

August 18, 2017

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

Presentation

Feasibility and Safety of Early Repeat Transradial Access Following Previous Angiography/PCI

August 09, 2017

News Daily News

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

Michael O'Riordan

August 09, 2017

News Daily News

ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year

Yael L. Maxwell

August 07, 2017

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

Presentation

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

August 04, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2017

Shelley Wood

July 31, 2017

News Daily News

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

L.A. McKeown

July 20, 2017

News Daily News

New-Generation DES Work Just Fine in Women With Acute MI

Todd Neale

June 29, 2017

News Daily News

Use of DAPT Score Following PCI Validated in PRODIGY Study

Yael L. Maxwell

June 12, 2017

News Daily News

As Pragmatic Trials Gain Steam, Beware the Pitfalls of Claims Data

Todd Neale

June 07, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

Presentation

Interaction Effects of Race/Ethnicity and Sex on Outcomes After PCI

May 18, 2017

News Conference News SCAI 2017

Minority Women Face 50% Increased Risk of Death/MI After PCI Compared With White Men at 1 Year

L.A. McKeown

May 18, 2017

News Conference News EuroPCR 2017

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Michael O'Riordan

May 18, 2017

News Conference News EuroPCR 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Michael O'Riordan

May 16, 2017

Advertisement

Underweight and Overlooked: Low BMI Patients May Be Highest-Risk Post-PCI

TAVR in the US: Regional Variations in Numbers, Outcomes

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Feasibility and Safety of Early Repeat Transradial Access Following Previous Angiography/PCI

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

TCTMD’s Top 10 Most Popular Stories for July 2017

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

New-Generation DES Work Just Fine in Women With Acute MI

Use of DAPT Score Following PCI Validated in PRODIGY Study

As Pragmatic Trials Gain Steam, Beware the Pitfalls of Claims Data

TCTMD’s Top 10 Most Popular Stories for May 2017

Interaction Effects of Race/Ethnicity and Sex on Outcomes After PCI

Minority Women Face 50% Increased Risk of Death/MI After PCI Compared With White Men at 1 Year

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content